Anti-zika virus agents and viral RdRp enzymatic inhibitors of derivatives of 5-membered pyrrolo[3,4-b]indol-3(4H)-one and 6-membered pyridazino[4,5-b]indol-4(5H)-one
Authors:
- Ren-Hua YangRYRen-Hua Yang
- Yong-Tang ZhengYZYong-Tang Zheng
- Guo-Chun ZhouGZGuo-Chun Zhou
- 7 March 2026
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 309, 118734
Abstract
No abstract availableKeywords
Funding Information
- Yunnan Key Research and Development Program (202403AC100033)
- National Natural Science Foundation of China (82570588,82460105)
- National Natural Science Foundation of China (82460105)
- National Natural Science Foundation of China (82570588)
- National Natural Science Foundation of China (82273820)
This publication has 60 references indexed in Scilit:
- NS2B‐NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic reviewJournal of Medical Virology, 2021
- Flavivirus enzymes and their inhibitors2021
- Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infectionFrontiers of Medicine, 2020
- Structural basis of Zika virus methyltransferase inhibition by sinefunginArchives of Virology, 2017
- The dengue virus NS5 protein as a target for drug discoveryAntiviral Research, 2015
- The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug developmentAntiviral Research, 2015
- Flavivirus methyltransferase: A novel antiviral targetAntiviral Research, 2008
- A new procedure for the cyclization of 2‐indole‐ and 3‐indolecarbohydrazones to 5H‐pyridazino[4,5‐b]indole derivativesJournal of Heterocyclic Chemistry, 1980
- Zika virus (II). Pathogenicity and physical propertiesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1952
- Zika Virus (I). Isolations and serological specificityTransactions of the Royal Society of Tropical Medicine and Hygiene, 1952